Filter registries KELA purch., KELA reimb.
Check pre-conditions None
Include endpoints None
Check conditions None
Apply sex-specific rule None
RX_HERPLUS
Extra metadata
List of similar endpoints to
Medicines for HER+ breast cancer
based on the number of shared cases.
Broader endpoints:
Narrower endpoints:
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | 6829 | 6731 | 98 |
| Unadjusted prevalence (%) | 2.63 | 4.58 | 0.09 |
| Mean age at first event (years) | 60.82 | 60.93 | 53.29 |
| Follow-up | Absolute risk | HR [95% CI] | p | N |
|---|---|---|---|---|
| 1998–2019 | 0.07 | 5.28 [3.96, 7.04] | 1.3e-29 | 482 |
| 15 years | 0.04 | 5.72 [4.33, 7.54] | 6.1e-35 | 454 |
| 5 years | 0.01 | 7.61 [5.91, 9.79] | 6.4e-56 | 223 |
| 1 year | 0.00 | 3.31 [2.06, 5.32] | 8.3e-7 | 21 |
Index endpoint: RX_HERPLUS – Medicines for HER+ breast cancer
GWS hits:
before Medicines for HER+ breast cancer
after Medicines for HER+ breast cancer
Loading survival analyses plot
Loading survival analyses table